Related Experiment Videos

Nonsunlight risk factors for malignant melanoma. Part II: Immunity, genetics, and workplace prevention

P F Rockley¹, N Trieff, R F Wagner

¹Department of Dermatology, University of Texas Medical Branch, Galveston 77555-0783.

International Journal of Dermatology

|July 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The novel AKT inhibitor afuresertib suppresses human Merkel cell carcinoma MKL-1 cell growth.

Clinical and experimental dermatology·2021

Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Polyomaviruses of the skin: integrating molecular and clinical advances in an emerging class of viruses.

The British journal of dermatology·2018

Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials.

The British journal of dermatology·2018

Dupilumab for Moderate-to-Severe Atopic Dermatitis.

Skin therapy letter·2017

Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

See all related articles